Yoshiro Tsukiyama Selected Research

ST Elevation Myocardial Infarction

4/2022	A serial optical frequency-domain imaging study of early and late vascular responses to bioresorbable-polymer sirolimus-eluting stents for the treatment of acute myocardial infarction and stable coronary artery disease patients: results of the MECHANISM-ULTIMASTER study.
10/2020	Vascular Response Occurring at 3 Months After Everolimus-Eluting Cobalt-Chromium Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction vs. Stable Coronary Artery Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshiro Tsukiyama Research Topics

Disease

5	Thrombosis (Thrombus) 01/2023 - 11/2018
5	Coronary Artery Disease (Coronary Atherosclerosis) 04/2022 - 10/2017
4	Atherosclerotic Plaque (Atheroma) 01/2020 - 10/2017
3	Myocardial Infarction 04/2022 - 10/2020
3	Neointima 10/2019 - 05/2016
2	ST Elevation Myocardial Infarction 04/2022 - 10/2020
1	Pathologic Constriction (Stenosis) 01/2023
1	Angina Pectoris 01/2023
1	Hypersensitivity (Allergy) 01/2023
1	Decompression Sickness (Bends) 12/2022
1	Hemorrhage 12/2020
1	Acute Coronary Syndrome 11/2018
1	AIDS-Related Complex (ARC) 10/2017

Drug/Important Bio-Agent (IBA)

2	Prasugrel Hydrochloride FDA Link 12/2020 - 11/2018
2	alirocumabIBA 01/2020 - 01/2019
2	Rosuvastatin Calcium (Crestor)FDA Link 01/2020 - 01/2019
1	MetalsIBA 01/2023
1	Phenobarbital (Luminal)FDA Link 01/2023
1	PolymersIBA 04/2022
1	Sirolimus (Rapamycin)FDA Link 04/2022
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 12/2020
1	CobaltIBA 10/2020
1	Everolimus FDA Link 10/2020
1	ChromiumIBA 10/2020
1	Glucose (Dextrose)FDA LinkGeneric 06/2018
1	Trans Fatty AcidsIBA 10/2017
1	LipidsIBA 10/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2017

Therapy/Procedure

8	Stents 01/2023 - 05/2016
2	Percutaneous Coronary Intervention 01/2023 - 01/2019
2	Drug-Eluting Stents 12/2020 - 10/2020
1	Catheters 12/2022
1	Therapeutics 11/2018